Ryosuke Ishida, Xi Zeng, Nagomi Kurebayashi, Takashi Murayama, Shuichi Mori, Yuga Yamamoto, Hiroyuki Kagechika. Development of RyR2 inhibitors with a parabanic acid skeleton as the core structure RSC Medicinal Chemistry. 2025.04; ( DOI )

Ishida Ryosuke, Zeng Xi, Kurebayashi Nagomi, Maruyama Takashi, Mori Shuichi, Kagechika Hiroyuki. リアノジン受容体2阻害剤の発見と構造活性相関(Discovery and Structure-Activity Relationship of a Ryanodine Receptor 2 Inhibitor) Chemical & Pharmaceutical Bulletin. 2024.04; 72 (4): 399-407. ( ichushi )

Ishida R, Zeng X, Kurebayashi N, Murayama T, Mori S, Kagechika H. Discovery and Structure-Activity Relationship of a Ryanodine Receptor 2 Inhibitor. Chemical & pharmaceutical bulletin. 2024; 72 (4): 399-407. ( PubMed, DOI )

Ishida R, Kurebayashi N, Iinuma H, Zeng X, Mori S, Kodama M, Murayama T, Masuno H, Takeda F, Kawahata M, Tanatani A, Miura A, Nishio H, Sakurai T, Kagechika H. A potent and selective cis-amide inhibitor of ryanodine receptor 2 as a candidate for cardiac arrhythmia treatment. European journal of medicinal chemistry. 2023.12; 262 115910. ( PubMed, DOI )

Xi Zeng, Ryosuke Ishida, Nagomi Kurebayashi, Hiroto Iinuma, Masami Kodama, Takashi Murayama, Hiroyuki Kagechika. A potent and selective cis-amide inhibitor of ryanodine receptor 2 as a candidate for cardiac arrhythmia treatment. 24th Tetrahedron Symposium 2024.06.19 Montpellier, France

Xi Zeng, Ryosuke Ishida, Nagomi Kurebayashi, Murayama Takashi, Yuuga Yamamoto, Shuichi Mori, Hiroyuki Kagechika. Development of novel RyR2 selective inhibitor. The 7th International Symposium on Biomedical Engineering 2022.11.25